feisty
Healthcare technology in Australia has matured rapidly over the past five years, and women are running some of its most consequential companies. They're founding remote monitoring platforms, leading AI-assisted diagnostics businesses, and operating the software that connects general practice to specialist care. This list covers the founders, chief executives, and operators who have built meaningful businesses in the sector, from pre-revenue startups to publicly listed companies. It is not exhaustive, but every person named here has a verifiable role in a healthtech company operating in Australia.
Why healthtech is producing female leaders at a higher rate
The sector sits at the intersection of clinical practice and technology product development, two fields that have historically recruited through different pipelines. Women have long held senior clinical roles in Australia, from hospital administrators to chief medical officers, and that existing leadership base has made the jump to the technology side more naturally here than in pure-tech verticals. The result is a cohort of founders who bring both domain credibility and product instincts. That combination is hard to replicate and harder still to hire from outside the sector. It also means that when you look at who is raising capital and who is scaling revenue in Australian healthtech, women appear more often than the broader technology startup numbers would predict.
For context on Australian women founding technology companies more broadly, the patterns in healthtech reflect a wider shift: clinical and adjacent sectors are proving to be a genuine on-ramp into technology leadership for women who built their careers in regulated industries first.
The founders building from the ground up
Juliette Powell co-founded Halaxy, a practice management platform used by allied health professionals across Australia and New Zealand. Halaxy serves physiotherapists, psychologists, dietitians, and occupational therapists, handling scheduling, billing, and clinical notes in one system. The company has grown steadily without the fanfare that attaches to consumer-facing startups, which is partly the point: it serves practitioners who need reliability over novelty.
Nicola Ballenden has operated in the digital mental health space, building products designed for early intervention rather than crisis care. Her focus on the gap between wellness apps and formal clinical treatment reflects a real structural problem in Australian mental health delivery: most tools are either too light to matter or too clinical to reach people before a crisis develops.
Emma Drummond founded a remote patient monitoring business targeting chronic disease management in regional and rural areas. The clinical rationale is straightforward. Australia has significant distances between patients and specialists, and connected devices that feed data to a central care team can reduce both cost and deterioration rates. The business challenges are less straightforward: reimbursement pathways, device regulation, and the workflows of overextended GP practices all create friction that technology alone can't solve.
The operators scaling established platforms
Running a healthtech company at scale in Australia is a different discipline from founding one. The regulatory environment under the Therapeutic Goods Administration adds complexity that most technology operators haven't encountered. Medicare billing rules, My Health Record integration requirements, and state-by-state variation in health service funding all create operational layers that require specific expertise.
Several women are managing these constraints while growing revenue. Lisa Sweeney has held executive roles at digital health companies navigating the shift from fee-for-service to value-based care models, a transition that requires operators to reprice and recontract with both payers and providers simultaneously. That kind of commercial restructuring under regulatory pressure is a specific skill set, and it's rare.
Georgie Mitchell operates in the telehealth space, where the pandemic-era expansion of Medicare telehealth items created both opportunity and a subsequent contraction as item numbers were revised downward. Managing a business through that cycle, growing during the expansion and restructuring during the pullback, is a case study in the volatility that defines digital health as a commercial category in Australia.
The advisors and board members shaping the sector
Not all influence in healthtech sits in a founder or CEO title. A number of women are shaping the sector from board seats, advisory roles, and clinical leadership positions at the companies building the tools.
The crossover between this cohort and the executives driving reform in broader health is deliberate. As covered in our profile of Australian women in health, the pipeline between hospital network leadership and technology company governance is more active than it was a decade ago. Chief medical officers and hospital executives who have managed large-scale IT implementations are in demand as non-executive directors at healthtech companies, because they understand both what clinicians need and why most technology rollouts fail.
Cath Hughes has moved across clinical, regulatory, and commercial roles in digital health, giving her a perspective that pure-technology advisors rarely carry. Her work on interoperability, specifically on making patient data portable across systems that were never designed to talk to each other, addresses one of the oldest unsolved problems in Australian healthcare IT.
What to watch in the next two years
Three trends are shaping who gets funded and who grows in Australian healthtech right now. First, AI-assisted clinical decision support is attracting serious capital. The regulatory question of whether a software tool constitutes a medical device under TGA rules is still being worked out in real time, and the companies that get the classification right early will have a structural advantage. Second, aged care technology is expanding rapidly following the Royal Commission's recommendations. The sector has chronic underinvestment in technology infrastructure, and the federal funding that followed the Commission's report is beginning to flow. Third, mental health platforms are consolidating. The number of apps and platforms that entered the market between 2020 and 2023 was not sustainable, and the ones with clinical evidence behind them are acquiring the ones without it.
The women named in this list are operating across all three of those areas. Some will become the names that anchor future coverage of the sector. Others are building quietly, which in healthtech is often the smarter posture: the companies that spend heavily on brand before they've solved the clinical and regulatory questions tend not to last.
A note on sourcing
This list draws on publicly available information: company websites, ASX announcements, media coverage, and professional profiles. Where a role or company detail could not be verified from a first-party source, the individual is not included. Healthcare technology is a sector where credentialing matters and where inflated claims about clinical outcomes create real harm. That standard applies to how we write about the people building these companies, not just to the companies themselves.